Powered by

Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging

Jan 09, 2019 - Business Wire
Mergers and Acquisitions-Partnership Announcement

On the final day of the largest biotechnology and pharmaceutical partnering week at the Juvenescence Longevity Showcase two leading longevity biotechnology companies, Elevian and Insilico Medicine, announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets. Elevian is an emerging biotech company developing medicines that restore youthful regenerative capacity, with the potential to treat and prevent the diseases of aging. Its f...